Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience

Leuk Lymphoma. 2019 Feb;60(2):488-492. doi: 10.1080/10428194.2018.1488252. Epub 2018 Aug 21.

Authors

Shimin Jasmine Chung^{1

2}, Rachel Ann Miller¹, Nitipong Permpalung¹, Arthur Wakefield Baker¹, Louis Frederic Diehl³, David Alan Rizzieri³, Barbara Dudley Alexander¹

Affiliations

¹ a Division of Infectious Diseases , Duke University , Durham , NC , USA.
² b Department of Infectious Diseases , Singapore General Hospital , Singapore , Singapore.
³ c Division of Hematological Malignancies and Cellular Therapy , Duke University Medical Center , Durham , NC , USA.

PMID: 30126315
DOI: 10.1080/10428194.2018.1488252

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Anti-Bacterial Agents / therapeutic use*
Antibiotic Prophylaxis*
Comorbidity
Critical Care
Cross Infection / diagnosis
Cross Infection / etiology
Cross Infection / prevention & control
Febrile Neutropenia / diagnosis
Febrile Neutropenia / etiology*
Febrile Neutropenia / prevention & control*
Female
Fluoroquinolones / therapeutic use*
Hematologic Diseases / complications*
Hematologic Diseases / therapy
Hospitalization
Humans
Male
Middle Aged
Odds Ratio
Sepsis / diagnosis
Sepsis / etiology*
Sepsis / prevention & control*
Treatment Outcome

Substances

Anti-Bacterial Agents
Fluoroquinolones